28.8 C
New York
Sunday, June 14, 2026

Tag: clinicians

NurExone Biologic Finalist in Falling Walls Venture 2025 Global Platform Showcasing The World’s Most Promising Science-Based Start-Ups

Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this November
Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this November

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Company to Pursue Technologies to Improve Muscle Strength, Bone Health, and Other Longevity Indicators NEW YORK, July 24, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO)...

Omniscient and The Jacobs Institute, Inc. Announce Strategic Partnership to Pioneer Clinical Connectomics

Omniscient and The Jacobs Institute launch Connectomics Innovation Program to advance stroke recovery and neurologic care with AI-enabled software.

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations
Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations

Aicuris Enrolled Last Participant in Pivotal Trial with Pritelivir to Treat Refractory Herpes Simplex Infection in Immunocompromised Patients

Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment of refractory and/or treatment resistant herpes simplex virus (HSV) infections in immunocompromised patients. The company’s lead candidate is a small molecule specifically inhibiting the viral helicase-primase complex, which represents a novel mechanism of action distinct from current HSV therapies.

iMedX Endorsed by Health New Zealand as Approved Ambient AI Scribe Tool

Partnership with DeliverHealth brings InstaNote (eSOne platform) to New Zealand clinicians AUCKLAND, New Zealand, July 23, 2025 /PRNewswire/ -- iMedX is proud to announce its formal endorsement by Health New Zealand | Te...

NAPA Anesthesia Honored with RPI Best Practice Standards® Award for Excellence in Employee Recognition

SUNRISE, Fla., July 23, 2025 /PRNewswire/ -- North American Partners in Anesthesia (NAPA), the nation's largest single-specialty anesthesia services organization, has been awarded a...

CharacterStrong and Intellispark Partner to Deliver Integrated MTSS Platform that Will Change How Schools Support Student Mental Health

Collaboration includes strategic investment by CharacterStrong’s parent company FullBloom to further scale K-12 mental health solutions that improve student outcomes
Collaboration includes strategic investment by CharacterStrong’s parent company FullBloom to further scale K-12 mental health solutions that improve student outcomes

Aidoc Secures $150M for CARE, its Healthcare Foundation Model, to Transform Clinical Decision-Making for 100 Million Patients

The Era of Clinical AI Has Arrived: Trusted by Leading Health Systems, Aidoc's Platform Brings AI to the Heart of Patient Care NEW YORK, July 23,...

Global Dental Leaders to Convene in Shanghai for FDI World Dental Congress 2025

SHANGHAI, July 23, 2025 /PRNewswire/ -- The FDI World Dental Congress (WDC), one of the world's premier events for the oral health profession, will...

Global Dental Leaders to Convene in Shanghai for FDI World Dental Congress 2025

SHANGHAI, July 23, 2025 /PRNewswire/ -- The FDI World Dental Congress (WDC), one of the world's premier events for the oral health profession, will...

Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients
Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients

BD Board Declares Dividend

FRANKLIN LAKES, N.J., July 22, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...

Llusern Scientific Announces Key Appointments to Strengthen its Executive Team

CTO, CMO and CFO appointments to advance the commercial launch of its precision point-of-care diagnostic Lodestar DX for UTIs worldwide
CTO, CMO and CFO appointments to advance the commercial launch of its precision point-of-care diagnostic Lodestar DX for UTIs worldwide

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsClinicians